/RBII

RBII Stock - Rising BioSciences, Inc.

Q: What is the analyst price target for RBII?

Analyst price target information is not currently available for RBII.

Q: What is RBII's market cap?

Market capitalization information is not currently available for RBII.

Healthcare|Medical - Pharmaceuticals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RBII

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta4.96

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2020	FY2019
Revenue	$782,280	$163,734
Gross Profit	$448,377	$-68,937
Gross Margin	57.3%	-42.1%
Operating Income	$284,170	$-179,260
Net Income	$49,762	$-253,233
Net Margin	6.4%	-154.7%
EPS	$0.00	$-0.00

Company Overview

Rising BioSciences, Inc. develops and manufactures topical and oral pharmaceutical products, including medical marijuana products. The company is based in Sheridan, Wyoming.

Visit Website

Frequently Asked Questions about RBII

What is RBII's current stock price?

Rising BioSciences, Inc. (RBII) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for RBII?

No analyst price targets are currently available for this stock.

What sector is Rising BioSciences, Inc. in?

Rising BioSciences, Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is RBII's market cap?

Rising BioSciences, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does RBII pay dividends?

No, Rising BioSciences, Inc. does not currently pay a dividend to shareholders.